Disc Medicine, Inc. (IRON) Stock Grade

About Disc Medicine, Inc.'s fundamentals

Disc Medicine is a biotechnology company with a $2.5 billion market capitalization that has not yet achieved profitability, posting a net loss in its latest annual statement with a net margin of 0.0%. The company generated zero year-over-year revenue growth, indicating no increase in sales compared to the prior year. With no dividend yield and the absence of meaningful profitability metrics, the company's financial returns remain in early-stage territory typical of development-stage biotechnology firms.